“Efficacy of Deucravacitinib over Time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-Blind, Placebo-Controlled Phase 3b 4 PSORIATYK SCALP Trial”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s537, https://doi.org/10.25251/skin.10.supp.537.